DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pjfvl7/global) has announced the addition of the "Global Neurovascular Market: Trends & Opportunities (2013-18)" report to their offering.
The global neurovascular industry is characterized by medical innovations and technological advancement, giving shape to a wide range of product offerings while offsetting pricing pressure at the same time. Mergers and acquisitions is a key trend witnessed by the neurovascular industry worldwide in the last few years. The acquisition of prominent players like Ev3 and Micrus has changed the dynamics of the neurovascular space, giving the market a more consolidated form. In addition, various government initiatives to improve healthcare infrastructure have provided the much needed boost to the neurovascular industry. The major companies operating in this market include Stryker, Medtronic, Covidien (Ev3) and Johnson & Johnson (Micrus).
'Global Neurovascular Market: Trends & Opportunities (2013-18)' provides a detailed insight into the neurovascular market. The report analyzes the primary segments of neurovascular disorders and the causes and symptoms associated with the disorder. It also assesses the various treatments available in the market and encompasses its market as well as its segments. The report also incorporates the market share based on various technologies and companies operating in this sphere. The report primarily focuses on the two chief segments of neurovascular disorder: hemorrhagic stroke and ischemic stroke. Further discussed are the various factors driving the neurovascular market in addition to profiles of the major companies operating in the market along with their business strategies and expansion plans.
Key Topics Covered:
1. Executive Summary
2. Neurovascular Industry: An Overview
3. Global neurovascular Market: Sizing and Growth
3.1. Market Sizing and Growth: Actual & Forecast
3.2. Neurovascular Market Share Analysis: By Technology & Major players
4. Segmentation of Neurovascular Market
4.1. Hemorrhagic Stroke Segment Analysis
4.2. Ischemic Stroke Segment Analysis
5. Neurovascular Market: Growth Drivers
5.1. Rising number of Diabetic Patients worldwide
5.2. Increasing Cases of Hypertension
5.3. Rising in the ageing population Worldwide
5.4. Illicit Consumption of Non-prescription Drugs
5.5. Rising Healthcare Expenditure
6. Company Analysis
6.2. Covidien (EV3)
6.3. Johnson and Johnson (Micrus)
For more information visit http://www.researchandmarkets.com/research/pjfvl7/global